Cancer remission due to immune impairment: A review report

Abstract

Immune develops in reaction to the presence of a cancerous tumor as it grows to a certain size, rather than through immunological sensitization. This is most likely due to the tumor’s slow growth, giving the immune system more time to acclimate to the new environment. Some immune system components generate “adaptive immunity” in response to a growing malignant growth, while other immune system components aim to prevent cancerous growth from developing. The immune system’s protective arm is often responsible for assuring the advancement of malignant growth. Because of the immunological tolerance, the immune system may misidentify the malignant growth as a component of the body with which it is already acquainted, adding to the protective impact. Immunological paralysis may be caused by a severe infection or a tumor mass that is excessively large. Both of these variables may lead immune system components entrusted with safeguarding the body against malignant growths to become overburdened and shut down. Immunological paralysis may be caused by any of these reasons. At this stage, several immune system components are no longer capable of providing any protection against the creation of malignant tumors. At this point, it is projected that the malignant disease will go into remission after a simple acute inflammation, followed by remission. This is because the inflammation would be followed by remission.